Centennial Medical Group, PA
Centennial Medical Group, PA was paid $1.53M by Medicaid between Jun 2018 and Dec 2024, across 63 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 39% of everything it billed.
COLUMBIA, MD 21045
Next to other Non-Pharmacy Dispensing Site providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25 | $974.66 | |
| 2019 | 16 | $371.52 | |
| 2020 | 145 | $4K | |
| 2021 | 8,428 | $361K | |
| 2022 | 10,681 | $571K | |
| 2023 | 8,106 | $310K | |
| 2024incomplete | 7,598 | $285K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 39% | 7,411 | 6,173 | $591K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 31% | 4,224 | 3,666 | $481K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 2,440 | 2,115 | $188K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.7% | 1,559 | 1,327 | $57K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.0% | 742 | 636 | $30K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.5% | 239 | 213 | $24K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.2% | 5,326 | 4,435 | $18K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 400 | 364 | $13K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 555 | 497 | $12K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,137 | 849 | $11K |
| 87535 | <1% | 704 | 519 | $11K | |
| 87538 | <1% | 704 | 518 | $11K |
51 more codes
| 87516 | <1% | 708 | $10K | |
| 87521 | Neg quan hep c or qual rna | <1% | 705 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 607 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 606 | $9K |
| 87641 | <1% | 447 | $6K | |
| 87653 | <1% | 358 | $6K | |
| 87500 | <1% | 359 | $6K | |
| 87640 | <1% | 305 | $4K | |
| 87481 | <1% | 448 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 81 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 542 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 670 | $2K |
| 80061 | Lipid panel | <1% | 426 | $2K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 47 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 77 | $2K |
| 87428 | <1% | 88 | $2K | |
| 96127 | <1% | 274 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 40 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 47 | $898.74 |
| 83735 | <1% | 522 | $716.73 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 297 | $517.50 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 87 | $516.75 |
| 0004A | <1% | 12 | $480.00 | |
| 99441 | <1% | 81 | $98.62 | |
| 81003 | <1% | 48 | $91.63 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 46 | $69.59 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 429 | $54.20 |
| 83721 | <1% | 30 | $52.34 | |
| 82310 | <1% | 28 | $41.30 | |
| 82374 | <1% | 28 | $39.00 | |
| 82540 | <1% | 28 | $37.10 | |
| 84520 | <1% | 28 | $31.60 | |
| 82947 | <1% | 28 | $31.40 | |
| 83718 | <1% | 21 | $13.10 | |
| 84478 | <1% | 21 | $9.18 | |
| 82565 | <1% | 33 | $9.13 | |
| 96160 | <1% | 20 | $8.31 | |
| 82465 | <1% | 21 | $6.96 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 71 | $0.00 |
| 82040 | 0% | 18 | $0.00 | |
| 3008F | 0% | 17 | $0.00 | |
| 99452 | 0% | 14 | $0.00 | |
| 84075 | 0% | 18 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 32 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 412 | $0.00 |
| 84460 | 0% | 18 | $0.00 | |
| 3725F | 0% | 243 | $0.00 | |
| 82248 | 0% | 18 | $0.00 | |
| 84450 | 0% | 18 | $0.00 | |
| 82247 | 0% | 18 | $0.00 | |
| 84155 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.